MTT assay for cell viability and growth

Rate this post

[ps2id id=’background’ target=”/]

BACKGROUND

The growth of cells can be determined by the reduction of tetrazolium salts in MTT assay. Metabolically active cells reduce the yellow tetrazolium MTT (3-(4, 5-dimethylthiazolyl-2)-2, 5-diphenyltetrazolium bromide), in part by the action of dehydrogenase enzymes, to create reducing equivalents such as NADH and NADPH. The intracellular purple formazan color results can be dissolved and quantified with spectrophotometric analysis. For the every cell type, the linear relationship between cell signal and its number produced is well established.1,2

Aim: Aim of this experiment is to study cell viability and growth by MTT assay.

[ps2id id=’requirements’ target=”/]

REQUIREMENTS

Sample:    Cell sample

Apparatus:    Microtiter plate reader with 650 nm and 570 nm filters

           Multi-channel pipette

           Microtiter plate (flat-bottomed)

           Sterile tubes – 5 ml

           Serological pipettes

           Sterile pipette tips

Instruments:    Inverted microscope

                         Incubator

             Laminar flow hood

Chemicals:    MTT reagent

           Detergent supplement

[ps2id id=’procedure’ target=”/]

PROCEDURE

Cells @ 1,000-100,000 per well were plated in the cultured plate and then incubated for 6 to 24 hours. After incubation 10 μl MTT reagent per well is added followed by additional incubation for 2 to 4 hours until purple precipitate is visible. Then add 100 μl of detergent reagent and leave at room temperature in the dark for 2 hours. Finally, absorbance is taken at 570 nm in a microtitre plate.3-5

Calculation

Mean OD treated cells/ mean OD control ×100 = % of viable cells

[ps2id id=’conclusion’ target=”/]

CONCLUSION

This experiment of MTT assay concludes that the cells are viable.

[ps2id id=’references’ target=”/][ps2id id=’1′ target=”/]

REFERENCES

  1. van de Loosdrecht, A.A., et al. J. Immunol. Methods 174: 311-320, 1994.
  2. Ferrari, M., et al. J. Immunol. Methods 131: 165-172, 1990.
  3. Gerlier, D., and N. Thomasset. J. Immunol. Methods 94: 57-63, 1986.
  4. Alley, M.C., et al. Cancer Res. 48: 589-601, 1988.
  5. Mosmann, T. J. Immunol. Methods 65: 55-63, 1983.